The latest closing stock price for Bone Biologics as of November 20, 2024 is 1.26.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2021 would have $-999 today, roughly -1 times their original investment - a -89.90% compound annual growth rate over 3 years.
The all-time high Bone Biologics stock closing price was 1315.20 on November 01, 2021.
The Bone Biologics 52-week high stock price is 10.56, which is 738.1% above the current share price.
The Bone Biologics 52-week low stock price is 0.80, which is 36.5% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 2.20.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2021 would have $-999 today, roughly -1 times their original investment - a -89.90% compound annual growth rate over 3 years.
The all-time high Bone Biologics stock closing price was 1315.20 on November 01, 2021.
The Bone Biologics 52-week high stock price is 10.56, which is 738.1% above the current share price.
The Bone Biologics 52-week low stock price is 0.80, which is 36.5% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 2.20.